These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 4094226)

  • 1. [Effect of calcium antagonists on the portal vein].
    Oomiya A; Kokumi N; Hagiwara Y; Hara T; Hirashima T
    Nihon Heikatsukin Gakkai Zasshi; 1985 Aug; 21(4):266-8. PubMed ID: 4094226
    [No Abstract]   [Full Text] [Related]  

  • 2. Inhibitor effects of diltiazem, nicardipine, nifedipine and verapamil on the norepinephrine-induced contractions of the canine saphenous vein in calcium-free medium.
    Saïag B; Milon D; Bentue-Ferrer D; Allain H; Rault B; Van den Driessche J
    Res Commun Chem Pathol Pharmacol; 1994 Mar; 83(3):255-69. PubMed ID: 8008975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of action of calcium antagonists on vascular smooth muscle].
    Kölling K
    Zentralbl Veterinarmed A; 1986 Feb; 33(2):99-110. PubMed ID: 3087115
    [No Abstract]   [Full Text] [Related]  

  • 4. [Mechanism of action of calcium-antagonists on the smooth vascular muscles].
    Ferrari R; Cargnoni A; Rodella A; Ciampalini G; Raddino R
    Cardiologia; 1985 May; 30(5):347-56. PubMed ID: 2421900
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effects of calcium antagonists on intracellular calcium deposits].
    Raddino R; Poli E; Pelà G; Ferrari A; Ghirarduzzi A; Ferrari R
    Cardiologia; 1987 Apr; 32(4):395-9. PubMed ID: 3113731
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of nilvadipine on regional cerebral blood flow and skin blood flow in anesthetized cats.
    Takakura S; Satoh Y; Satoh H; Mori J; Kohsaka M
    Arch Int Pharmacodyn Ther; 1992; 319():38-48. PubMed ID: 1285672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of nilvadipine on the cardiovascular system in experimental animals.
    Ohtsuka M; Koibuchi Y; Sakai S; Tsujioka K; Fujiwara T; Ozaki T; Maeda K; Motoyama I; Horiai H; Ono T
    Arzneimittelforschung; 1988 Nov; 38(11):1605-18. PubMed ID: 3214444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Experimental studies on hepatic circulation: effects of drugs on blood flows in liver tissue and portal vein of the cats].
    Ohmiya A
    Nihon Heikatsukin Gakkai Zasshi; 1986 Dec; 22(6):483-92. PubMed ID: 3041088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of calcium antagonists on adrenergic mechanisms in canine saphenous veins.
    Jayakody RL; Kappagoda CT; Senaratne MP
    J Physiol; 1986 Mar; 372():25-39. PubMed ID: 3723410
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue selectivity of the novel calcium antagonist sesamodil fumarate in isolated smooth muscles and cardiac muscles.
    Nishimura K; Miyawaki N; Yamauchi H; Iso T
    Arzneimittelforschung; 1990 Mar; 40(3):244-8. PubMed ID: 2112000
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combined use of propranolol and nifedipine offers better effects on portal vein nonuniform remodeling in carbon tetrachloride (CCl(4))-induced portal hypertensive rats.
    Zhang ZQ; Shi B; Wu GQ; Qin KR; Jiang ZL; Zhu L
    Eur J Pharmacol; 2009 Jun; 613(1-3):108-13. PubMed ID: 19401196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypertension: calcium-blocking agents in treatment.
    Ambrose JE
    J Am Osteopath Assoc; 1984 Jan; 83(5):353-60. PubMed ID: 6321407
    [No Abstract]   [Full Text] [Related]  

  • 13. Effect of ryodipine on electromechanical parameters of heart and vessels, cAMP phosphodiesterase activity and swelling-contraction cycle of mitochondria.
    Velena AH; Dubur GJ; Vitolina RO; Kimenis AA; Selga MJ; Zarinsh GV; Narusevicius EV; Macianskiene RA; Gendvilienè VI; Simkhovich BZ
    Arzneimittelforschung; 1985; 35(6):907-14. PubMed ID: 2992533
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of the Ca(2+)-channel agonist Bay K 8644 on the contractile responses in human placental veins.
    Barrús MT; Reviriego J; Marín J
    J Auton Pharmacol; 1996 Jun; 16(3):161-7. PubMed ID: 8884463
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Calcium antagonist and the peripheral circulation: differences and similarities between PY 108-068, nicardipine, verapamil and diltiazem.
    Hof RP
    Br J Pharmacol; 1983 Feb; 78(2):375-94. PubMed ID: 6831117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of the cardiovascular effect of FR34235, a new dihydropyridine, with other calcium antagonists.
    Ohtsuka M; Ono T; Hiroi J; Esumi K; Kikuchi H; Kumada S
    J Cardiovasc Pharmacol; 1983; 5(6):1074-82. PubMed ID: 6196557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcium entry blocker activity of cyproheptadine in isolated cardiovascular preparations.
    Winquist RJ; Siegl PK; Baskin EP; Bohn DL; Morgan G; Wallace AA
    J Pharmacol Exp Ther; 1984 Jul; 230(1):103-9. PubMed ID: 6747822
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Calcium antagonistic properties of nicardipine, a dihydropyridine derivative assessed in isolated cerebral arteries and cardiac muscle.
    Nakayama K; Kurihara J; Miyajima Y; Ishii K; Kato H
    Arzneimittelforschung; 1985; 35(4):687-93. PubMed ID: 4015735
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rapid large artery remodeling following the administration and withdrawal of calcium channel blockers in spontaneously hypertensive rats.
    Vaja V; Ochodnicky P; Krenek P; Klimas J; Bajuszova Z; Kyselovic J
    Eur J Pharmacol; 2009 Oct; 619(1-3):85-91. PubMed ID: 19683522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Excitation-contraction coupling in cardiac and vascular smooth muscle: modification by calcium-entry blockade.
    McCall D
    Circulation; 1987 Jun; 75(6 Pt 2):V3-14. PubMed ID: 2436829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.